Cryo-EM structure of severe fever with thrombocytopenia syndrome virus.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
10 10 2023
Historique:
received: 23 02 2023
accepted: 19 09 2023
medline: 1 11 2023
pubmed: 11 10 2023
entrez: 10 10 2023
Statut: epublish

Résumé

The severe fever with thrombocytopenia syndrome virus (SFTSV) is a tick-borne human-infecting bunyavirus, which utilizes two envelope glycoproteins, Gn and Gc, to enter host cells. However, the structure and organization of these glycoproteins on virion surface are not yet known. Here we describe the structure of SFTSV determined by single particle reconstruction, which allows mechanistic insights into bunyavirus assembly at near-atomic resolution. The SFTSV Gn and Gc proteins exist as heterodimers and further assemble into pentameric and hexameric peplomers, shielding the Gc fusion loops by both intra- and inter-heterodimer interactions. Individual peplomers are associated mainly through the ectodomains, in which the highly conserved glycans on N914 of Gc play a crucial role. This elaborate assembly stabilizes Gc in the metastable prefusion conformation and creates some cryptic epitopes that are only accessible in the intermediate states during virus entry. These findings provide an important basis for developing vaccines and therapeutic drugs.

Identifiants

pubmed: 37816705
doi: 10.1038/s41467-023-41804-7
pii: 10.1038/s41467-023-41804-7
pmc: PMC10564799
doi:

Substances chimiques

Viral Envelope Proteins 0
Glycoproteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6333

Informations de copyright

© 2023. Springer Nature Limited.

Références

Yu, X. J. et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364, 1523–1532 (2011).
pubmed: 21410387 pmcid: 3113718
Kim, K. H. et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg. Infect. Dis. 19, 1892–1894 (2013).
pubmed: 24206586 pmcid: 3837670
Takahashi, T. et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J. Infect. Dis. 209, 816–827 (2014).
pubmed: 24231186
Tran, X. C. et al. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg. Infect. Dis. 25, 1029–1031 (2019).
pubmed: 31002059 pmcid: 6478219
Zhang, N. et al. Modelling the transmission dynamics of severe fever with thrombocytopenia syndrome in Jiangsu Province, China. Parasit Vectors 14, 237 (2021).
pubmed: 33957950 pmcid: 8100741
Jiang, X. L. et al. A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China. Clin. Microbiol. Infect. 21, 274–279 (2015).
pubmed: 25687766
Zhuang, L. et al. Transmission of severe fever with thrombocytopenia syndrome virus by Haemaphysalis longicornis ticks, China. Emerg. Infect. Dis. 24, 868–871 (2018).
pubmed: 29664718 pmcid: 5938789
Mehand, M. S., Al-Shorbaji, F., Millett, P. & Murgue, B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 159, 63–67 (2018).
pubmed: 30261226 pmcid: 7113760
ICTV. ICTV taxonomy history: SFTS virus, https://talk.ictvonline.org/taxonomy/p/taxonomy-history?taxnode_id=20141803&src=NCBI&ictv_id=20141803 (2020).
Yuan, F. & Zheng, A. Entry of severe fever with thrombocytopenia syndrome virus. Virol. Sin. 32, 44–50 (2017).
pubmed: 27995422
Elliott R. M. & Schmaljohn C. S. Bunyaviruses. In: Knipe D. M., Howley P. M., editors. Fields Virology. 5th edition ed. Lipincott Williams & Wilkins (2013).
Lozach, P. Y. et al. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 10, 75–88 (2011).
pubmed: 21767814
Sun, Y. et al. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus. J Virol 88, 237–248 (2014).
pubmed: 24155382 pmcid: 3911693
Hofmann, H. et al. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J. Virol. 87, 4384–4394 (2013).
pubmed: 23388721 pmcid: 3624395
Freiberg, A. N., Sherman, M. B., Morais, M. C., Holbrook, M. R. & Watowich, S. J. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J. Virol. 82, 10341–10348 (2008).
pubmed: 18715915 pmcid: 2573222
Huiskonen, J. T., Overby, A. K., Weber, F. & Grunewald, K. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J. Virol. 83, 3762–3769 (2009).
pubmed: 19193794 pmcid: 2663282
Sherman, M. B., Freiberg, A. N., Holbrook, M. R. & Watowich, S. J. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology 387, 11–15 (2009).
pubmed: 19304307
Overby, A. K., Pettersson, R. F., Grunewald, K. & Huiskonen, J. T. Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl Acad. Sci. USA 105, 2375–2379 (2008).
pubmed: 18272496 pmcid: 2268144
Serris, A. et al. The hantavirus surface glycoprotein lattice and its fusion control mechanism. Cell 183, 442–456 e416 (2020).
pubmed: 32937107 pmcid: 7572791
Wu, Y. et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc. Natl Acad. Sci. USA 114, E7564–E7573 (2017).
pubmed: 28827346 pmcid: 5594662
Halldorsson, S. et al. Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion. Proc. Natl Acad. Sci. USA 113, 7154–7159 (2016).
pubmed: 27325770 pmcid: 4932967
Dessau, M. & Modis, Y. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc. Natl Acad. Sci. USA 110, 1696–1701 (2013).
pubmed: 23319635 pmcid: 3562824
Guardado-Calvo, P. et al. A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. Science 358, 663–667 (2017).
pubmed: 29097548
Kim, K. H. et al. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog. 15, e1007375 (2019).
pubmed: 30707748 pmcid: 6380599
Guo, X. et al. Human antibody neutralizes severe fever with thrombocytopenia syndrome virus, an emerging hemorrhagic fever virus. Clin. Vaccine Immunol. 20, 1426–1432 (2013).
pubmed: 23863504 pmcid: 3889583
Moming, A. et al. Fine mapping epitope on glycoprotein-Gn from severe fever with thrombocytopenia syndrome virus. PLoS ONE 16, e0248005 (2021).
pubmed: 33651850 pmcid: 7924767
Sanchez, R. M., Zhang, Y., Chen, W., Dietrich, L. & Kudryashev, M. Subnanometer-resolution structure determination in situ by hybrid subtomogram averaging - single particle cryo-EM. Nat. Commun. 11, 3709 (2020).
pubmed: 32709843 pmcid: 7381653
Zhu, D. et al. Pushing the resolution limit by correcting the Ewald sphere effect in single-particle Cryo-EM reconstructions. Nat. Commun. 9, 1552 (2018).
pubmed: 29674632 pmcid: 5908801
Wang, Q. et al. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat. Microbiol. 4, 1231–1241 (2019).
pubmed: 30936489
Guardado-Calvo, P. et al. Mechanistic insight into bunyavirus-induced membrane fusion from structure-function analyses of the hantavirus envelope glycoprotein Gc. PLoS Pathog. 12, e1005813 (2016).
pubmed: 27783711 pmcid: 5082683
Lescar, J. et al. The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105, 137–148 (2001).
pubmed: 11301009
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291–298 (1995).
pubmed: 7753193
Kampmann, T., Mueller, D. S., Mark, A. E., Young, P. R. & Kobe, B. The role of histidine residues in low-pH-mediated viral membrane fusion. Structure 14, 1481–1487 (2006).
pubmed: 17027497
Song, H. et al. Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to chikungunya virus envelope protein. Cell 177, 1714–1724 (2019).
pubmed: 31080063
Basore, K. et al. Cryo-EM structure of chikungunya virus in complex with the Mxra8 receptor. Cell 177, 1725–1737 (2019).
pubmed: 31080061 pmcid: 7227486
Mangala Prasad, V., Klose, T. & Rossmann, M. G. Assembly, maturation and three-dimensional helical structure of the teratogenic rubella virus. PLoS Pathog. 13, e1006377 (2017).
pubmed: 28575072 pmcid: 5470745
Sun, S. Y. et al. Structural analyses at pseudo atomic resolution of chikungunya virus and antibodies show mechanisms of neutralization. Elife 2, e00435 (2013).
pubmed: 23577234 pmcid: 3614025
Yuan, S. A. et al. Cryo-EM structure of a herpesvirus capsid at 3.1 angstrom. Science 360, eaao7283 (2018).
pubmed: 29622627
Dowd, K. A. & Pierson, T. C. The many faces of a dynamic virion: implications of viral breathing on flavivirus biology and immunogenicity. Annu. Rev. Virol. 5, 185–207 (2018).
pubmed: 30265634
Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696–704 (2016).
pubmed: 27158114
Franca, R. et al. New anti-flavivirus fusion loop human antibodies with zika virus-neutralizing potential. Int. J. Mol. Sci. 23, https://doi.org/10.3390/ijms23147805 (2022).
Deng, Y.-Q. et al. A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS ONE 6, e16059 (2011).
pubmed: 21264311 pmcid: 3019176
Halldorsson, S. et al. Shielding and activation of a viral membrane fusion protein. Nat. Commun. 9, 349 (2018).
pubmed: 29367607 pmcid: 5783950
Sun, Z. et al. Architecture of severe fever with thrombocytopenia syndrome virus. Protein Cell https://doi.org/10.1093/procel/pwad019 (2023).
Cheng, J., Li, B., Si, L. & Zhang, X. Determining structures in a native environment using single-particle cryoelectron microscopy images. Innovation (Camb) 2, 100166 (2021).
pubmed: 34632438
Zhang, X. et al. First fatal infection and phylodynamic analysis of severe fever with thrombocytopenia syndrome virus in Jilin province, northeastern China. Virol. Sin. 36, 329–332 (2021).
pubmed: 32458298
Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493–497 (1938).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
pubmed: 28250466 pmcid: 5494038
Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76 (1996).
pubmed: 8742726
Himes, B. A. & Zhang, P. emClarity: software for high-resolution cryo-electron tomography and subtomogram averaging. Nat. Methods 15, 955–961 (2018).
pubmed: 30349041 pmcid: 6281437
Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
pubmed: 23000701 pmcid: 3690530
Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
pubmed: 26592709 pmcid: 4711343
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 7, e42166 (2018).
pubmed: 30412051 pmcid: 6250425
Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local resolution of cryo-EM density maps. Nat. Methods 11, 63–65 (2014).
pubmed: 24213166
Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
pubmed: 15264254
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
pubmed: 20124702 pmcid: 2815670
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002 pmcid: 2852313
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
pubmed: 20057044
Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
pubmed: 8744570
Roberts, E., Eargle, J., Wright, D. & Luthey-Schulten, Z. MultiSeq: unifying sequence and structure data for evolutionary analysis. BMC Bioinf. 7, 382 (2006).
Xu, W. et al. Transmembrane domain of IFITM3 is responsible for its interaction with influenza virus HA2 subunit. Virol. Sin. 37, 664–675 (2022).
pubmed: 35809785 pmcid: 9583175

Auteurs

Shouwen Du (S)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China.
The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, China.
Department of Infectious Diseases and Center for Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, The First Hospital of Jilin University, Changchun, China.

Ruchao Peng (R)

Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Wang Xu (W)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Xiaoyun Qu (X)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China.
Key Laboratory of Zoonosis of Ministry of Agriculture and Rural Affairs, South China Agricultural University, Guangzhou, China.

Yuhang Wang (Y)

The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, China.

Jiamin Wang (J)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Letian Li (L)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Mingyao Tian (M)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Yudong Guan (Y)

The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, China.

Jigang Wang (J)

The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, China.

Guoqing Wang (G)

Department of Infectious Diseases and Center for Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, The First Hospital of Jilin University, Changchun, China.

Hao Li (H)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.

Lingcong Deng (L)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Xiaoshuang Shi (X)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Yidan Ma (Y)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Fengting Liu (F)

The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, China.

Minhua Sun (M)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China.

Zhengkai Wei (Z)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China.

Ningyi Jin (N)

Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Wei Liu (W)

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. lwbime@163.com.

Jianxun Qi (J)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. jxqi@im.ac.cn.
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China. jxqi@im.ac.cn.

Quan Liu (Q)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China. liuquan1973@hotmail.com.
Department of Infectious Diseases and Center for Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, The First Hospital of Jilin University, Changchun, China. liuquan1973@hotmail.com.
Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Institute of Zoology, Guangdong Academy of Sciences, Foshan University, Foshan, China. liuquan1973@hotmail.com.

Ming Liao (M)

Key Laboratory of Livestock Disease Prevention of Guangdong Province, Scientific Observation and Experiment Station of Veterinary Drugs and Diagnostic Techniques of Guangdong Province, Ministry of Agriculture and Rural Affairs, Institute of Animal Health, Guangdong Academy of Agricultural Sciences, Guangzhou, China. mliao@scau.edu.cn.
Key Laboratory of Zoonosis of Ministry of Agriculture and Rural Affairs, South China Agricultural University, Guangzhou, China. mliao@scau.edu.cn.

Chang Li (C)

Department of Infectious Diseases and Center for Infectious Diseases and Pathogen Biology, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, The First Hospital of Jilin University, Changchun, China. lichang78@163.com.
Research Unit of Key Technologies for Prevention and Control of Virus Zoonoses, Chinese Academy of Medical Sciences, Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China. lichang78@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH